- Ekso Bionics (EKSO, Financial) has been accepted into the NVIDIA Connect program to enhance its AI capabilities.
- The collaboration aims to develop the first foundation model for human motion in physical rehabilitation.
- Ekso Bionics gains access to NVIDIA's specialized training, engineering support, and exclusive GPU development platforms.
Ekso Bionics Holdings, Inc. (EKSO) has announced its acceptance into the prestigious NVIDIA Connect program. This strategic move is anticipated to significantly boost the company's AI development strategy, specifically in the realm of exoskeleton technology used in physical rehabilitation. By leveraging NVIDIA’s resources and support, Ekso Bionics aims to create the world’s first foundation model for human motion, a development that could revolutionize rehabilitation protocols.
This partnership through the NVIDIA Connect program allows Ekso to utilize specialized training and access priority engineering support. Moreover, Ekso Bionics will benefit from exclusive NVIDIA GPU platforms and development kits, providing them with resources that would otherwise be costly and complex to develop independently.
The integration of new AI capabilities across Ekso Bionics’ Enterprise Health and Personal Health device portfolios is expected to enhance existing exoskeleton technology platforms. This could lead to more personalized rehabilitation protocols, improving patient outcomes by enabling devices to better understand and adapt to individual movement patterns.
Scott Davis, CEO of Ekso Bionics, emphasized that while their exoskeleton technology is already advanced, this collaboration marks just the beginning of their journey in AI-enhanced rehabilitation technology. With the potential for real-time adaptability in their devices, Ekso Bionics is poised to make strides from offering assistive devices to developing intelligent rehabilitation partners.
